Helus Pharma Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
11.80
+1.08 (10.07%)
At close: Oct 9, 2026, 4:00 PM EDT
11.95
+0.15 (1.27%)
After-hours: Oct 9, 2026, 7:59 PM EDT
Helus Pharma Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Helus Pharma stock has a consensus rating of "Strong Buy" and an average price target of $39.99. The average 1-year stock price forecast is 238.90% higher than the current stock price, while the lowest is $14.86 (+25.93%) and the highest is $69.95 (+492.80%).
Price Target: $39.99 (+238.90%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Helus Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 10 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +493.22% | Oct 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $22 | Buy | Maintains | $22 | +86.44% | Oct 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $42 | Buy | Reiterates | $42 | +255.93% | Sep 23, 2026 |
| Barclays | Barclays | Buy Initiates $35 | Buy | Initiates | $35 | +196.61% | Sep 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $16 | Buy | Maintains | $16 | +35.59% | Sep 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
7.76M
EPS This Year
-2.61
from -4.14
EPS Next Year
-1.78
from -2.61
EPS and Forward PE are based on non-GAAP adjusted numbers.